Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Learn How to Align Healthcare Practice with Technology for Better Patient Outcomes at Collaborative Innovation in Healthcare: A Frost & Sullivan Executive MindXchange 2018-09-19 20:12
Seegene Unveils New Real-time PCR Analysis Technology, Drastically Increasing Its Multiplexing Capacity 2018-09-19 20:00
I-Mab Wins Frost & Sullivan "2018 Best R&D Innovator Award (Biopharma Category)" 2018-09-19 15:33
Novo Holdings Acquires a 25% Equity Stake in Envirotainer 2018-09-19 14:27
Menarini Ricerche Announces New Positive Results in Acute Myeloid Leukemia Cell Lines for MEN1112/OBT357 at the 60th Annual SIC Meeting 2018-09-19 08:00
For High-Volume Pathology Labs, HistoCore SPECTRA Workstation Delivers Immediately Dry Slides at Faster Turnaround Times 2018-09-18 21:00
Flagship Biosciences Recognized by Frost & Sullivan for Its Industry-leading AI-powered cTA® Platform for Predictive Diagnostics 2018-09-18 20:00
WuXi Biologics' Chief Quality Officer Received Foreign Post Service Award from FDA 2018-09-18 08:08
Anti-migraine Head Patch - HeadaTerm - Receives FDA Clearance 2018-09-17 21:00
DOJ Closes Investigation of Sinovac 2018-09-17 19:00
Eternity Healthcare Inc. Expects to Complete Stem Cell Facility and Commence Operations by the End of Year and Declare a 2.5 for 1 Stock Dividend 2018-09-17 18:30
Experts Call for Improved Identification of 'High Burden' Rosacea Patients in Everyday Practice 2018-09-14 21:56
Schizophrenia Breakthrough Discovered at Neuroscience Research Australia (NeuRA) 2018-09-14 02:30
Allergan Partners with Alibaba Health to Launch Digital Platform to Serve Chinese Medical Aesthetics Market 2018-09-13 09:00
Mundipharma to provide access to a new range of children's consumer healthcare treatments in the Middle East, Turkey and Africa 2018-09-12 18:05
ExoCoBio Inc. raises $26.7M in Series B Funding 2018-09-12 17:37
Recent Revisions in Chinese Regulations Open New Doors for Contract Research Organizations: Accutest 2018-09-12 11:30
BAVENCIO® (avelumab) Plus INLYTA® (axitinib) Significantly Improved Progression-Free Survival in Previously Untreated Patients With Advanced Renal Cell Carcinoma in Phase III Study 2018-09-11 21:30
The 9th China (Taizhou) International Medical Expo is coming soon 2018-09-11 17:31
WuXi Biologics and Inhibrx Enter an Exclusive Partnership for GMP Manufacturing 2018-09-11 08:38
1 693 694 695 696 697 970